Brian Coe is Chief Executive Officer and co-founder of SlipChip Corporation, which is developing a micro-fluidic platform for conducting quantitative molecular assays for use in research and clinical laboratories. He currently serves as Chairman of Euclid Diagnostics, an epigenetics company he co-founded and is an adjunct professor of entrepreneurship at the University of Chicago Booth School of Business.

Previously, Mr. Coe was a Senior Vice President at The Laboratory Corporation of America (NYSE:LH). Prior to joining LabCorp, he co-founded and served as the Chief Executive Officer of Litholink Corporation, a specialty laboratory that embedded sophisticated clinical decision support into its reports in order to help physicians manage recurrent kidney stone formation. LabCorp acquired Litholink in November 2006.

Mr. Coe earned an MBA from Chicago Booth and a BA in neuroscience and psychology from Brandeis University.